An observational cohort assessing effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China
Latest Information Update: 21 Jul 2021
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Community-acquired pneumonia
- Focus Therapeutic Use
- 21 Jul 2021 New trial record
- 09 Jul 2021 Results assessing direct effectiveness of PCV13 against community acquired pneumonia (CAP) associated with PCV13 serotype carriage (VT-CAP) published in the Vaccine